On Monday, Piper Sandler adjusted the stock price target for Cytek Biosciences Inc (NASDAQ:CTKB), decreasing it to $8.25 from the previous $8.50, while maintaining an Overweight rating on the stock.
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
TAMPA, FL - TuHURA Biosciences Inc. (NASDAQ:HURA) announced significant advancements in its pipeline of cancer immunotherapies, including an upcoming Phase 3 trial for its leading drug candidate IFx-2 ...
isa_ozdere / Getty Images IOTA is a distributed ledger platform designed for the Internet of Things, enterprise needs, eHealth, and digital identity ecosystems. Its native token, IOTA ...
On the buying side, ARK showed continued interest in Pacific Biosciences (NASDAQ:PACB) of California Inc (NASDAQ:PACB), acquiring 33,764 shares across its ARKK and ARKG ETFs, valued at $58,074. This ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
CAMBRIDGE, Mass. - Enveric Biosciences Inc. (NASDAQ: ENVB), a biotechnology company specializing in the development of treatments for mental health disorders, has entered into a licensing agreement ...
On the buying side, ARK's largest acquisition was in Pacific Biosciences (NASDAQ:PACB) of California Inc (NASDAQ:PACB), purchasing over a million shares across ARKK and ARKG ETFs, amounting to $2.32 ...
Revenue: US$40.0m (down 28% from 3Q 2023). Net loss: US$60.7m (loss narrowed by 9.2% from 3Q 2023). US$0.22 loss per share (improved from US$0.26 loss in 3Q 2023). Revenue missed analyst estimates ...
On Monday (NASDAQ:MNDY), H.C. Wainwright adjusted its stock price target for Tyra Biosciences (NASDAQ:TYRA), a company specializing in precision medicine oncology drugs. The firm reduced the price ...
TL;DR: President-elect Trump's victory in the 2024 US elections has accelerated efforts by TSMC and its Taiwanese semiconductor supply chain partners to establish new factories in the US.